According to data obtained through a whistleblower via a Freedom Of Information Act request, Australia’s Therapeutic Goods Administration (TGA) and the New Zealand health authority responsible for ensuring medicines are safe for the public, published a report with redactions in Jan. 2021 admitting that mRNA particles don’t just stay at the injection site but rapidly spread throughout the body.
In one key finding in the study (“Nonclinical Evaluation of BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)”), which documented rats post-Pfizer injection, researchers noted they observed distribution of lipid nanoparticles in plasma in the liver, adrenal glands, spleen and ovaries.
“Of course, the ovaries store and mature the ovum (female reproductive cells), so I’m not gonna pretend I’m not a little concerned about this, I’m more than a little concerned actually,” Dr. John Campbell noted.
Another distressing section of the report notes “slow but significant distribution of lipid nanoparticles from the site of injection with major uptake into liver.“
Dr. Campbell explained “that means the mRNA could go into the vascular endothelial cells in the liver into the hepatocytes themselves, produce the spike protein, that will be expressed, and there will be an inflammatory reaction against that spike protein in the liver.”
“This is not what we were told,” Dr. Campbell emphasized.
“How could the Australian health authorities know this back in 2021 and still approve this vaccine?” he questioned.
Here’s a list of all the locations in the body concentrations of mRNA lipid nanoparticles were discovered, including the eyes, heart, pituitary gland and pancreas:
“Given that this was known, why were the vaccines given authorization when they were?” Dr. Campbell asked, concluding his report.
Australian Gov’t Hid Evidence That mRNA Particles Infect Brain, Liver & Ovaries With Disease
